Patients taking the drug nearly doubled their survival time, with fewer severe side effects.

The therapy is a brand new targeted drug for the disease which experts have labelled as a substantial breakthrough following doubling of survival time in a trial.

When the FDA approved a new pancreatic cancer drug called Rasonque, researchers celebrated. But some patients hoping for ...

Merck and Moderna’s success with a personalized cancer vaccine designed to keep melanoma at bay opens a ​new avenue of treatment that doctors hope will work against many types of tumors.

A new jab extended the length of time patients were cancer free, but it is unclear for how long.

New trial results indicate that the targeted cancer drug Daraxonrasib might also be beneficial for some patients with lung cancer.

The FDA approved Daraxonrasib, a promising new cancer pill researched in Scottsdale.

Rasonque may help people with advanced pancreatic cancer live longer while offering a new treatment option in addition to ...

Optimism about a potential breakthrough in personalised cancer treatment has sent shares in Moderna soaring by nearly 100%.

A groundbreaking once-daily pill nearly doubled median survival compared with chemotherapy in a major trial involving ...

Rasonque, the new pancreatic cancer treatment from Revolution Medicines, illustrates the huge inflation in cancer drug prices ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Researchers have unveiled a breakthrough showing that a subset of ...